Addex Therapeutics Ltd. (ADXN) stock
ADXNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.50−0.33 (-8.62%)
Close on Nov 17, 2026Market cap $71.86KP/E –Yield –
Addex Therapeutics operating margin
Operating margin is operating income as a percentage of revenue.
For fiscal 2025 it was -9390.8%, against -681.8% the year before. The highest annual figure on record is -23.6% in fiscal 2018.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -9390.8% | −8708.9 |
| FY2024 | Dec 31, 2024 | -681.8% | −542.8 |
| FY2023 | Dec 31, 2023 | -139.1% | +602.0 |
| FY2022 | Dec 31, 2022 | -741.0% | −209.3 |
| FY2021 | Dec 31, 2021 | -531.7% | −192.8 |
| FY2020 | Dec 31, 2020 | -338.9% | +189.7 |
| FY2019 | Dec 31, 2019 | -528.6% | −505.0 |
| FY2018 | Dec 31, 2018 | -23.6% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2024 | Jun 30, 2024 | -780.1% | – |
| Q2 FY2023 | Jun 30, 2023 | -403.7% | – |
| Q2 FY2022 | Jun 30, 2022 | -3868.0% | – |
| Q2 FY2021 | Jun 30, 2021 | -454.0% | – |
See a number that looks wrong?